Skip to content
Catalyst

cyanocob(III)alaminFinding

cyanocob(III)alamin decreases numeric rating scale (NRS) pain intensity

lowersVery limited evidenceFinding

01 · The sentence it was drawn from

“Compared with the placebo group, the Vitamin B12 group exhibited a significant decrease in the Numeric Rating Scale score, with a mean difference of -4.01 (95% confidence interval = -4.70 to -3.33).”
Quoted verbatim from Vitamin B12 for herpetic neuralgia: A meta-analysis of randomised controlled trials.
This finding among the 5 findings on its endpoint

cyanocob(III)alamin

Numeric rating scale (NRS) pain intensity

lowers

Effect as reported

−4.01mean difference

CI −4.7 to −3.33

Who
Patients with postherpetic neuralgia; pooled randomised trials of vitamin B12 against placebo
Dose studied
not reported

Very limited evidencePMID 30477853 · 2018

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

03 · The paper

Complementary therapies in medicine
What else it reported2 findings · 1 compound · 2 endpoints

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M702P9TX58SH7BEW5PT81HSF